Graft Versus Host Disease (GVHD)

Matt Kalaycio, MD, FACP, is the former Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic Taussig Cancer Institute. Dr. Kalaycio is also a Professor in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Board-certified in hematology, Dr. Kalaycio's clinical interests are in leukemia and hematopoietic cell transplantation. Dr. Kalaycio has published over 200 articles in numerous scientific publications including Bone Marrow Transplantation, Journal of Clinical Oncology, and Leukemia. He serves on the editorial board of Biology of

Dr Mattison is an associate professor of medicine within the division of hematology/oncology at the University of Wisconsin School of Medicine and Public Health. He earned his medical degree at the University of Iowa Carver College of Medicine, Iowa City, IA. He completed his residency at University of North Carolina Hospitals, Chapel Hill, NC and his fellowship at the University of Chicago Hospitals, Chicago, IL. Dr. Mattison is board-certified in internal medicine, medical oncology and hematology.

Sarah Bannon is a Senior Genetic Counselor in the Department of Clinical Cancer Genetics at the UT MD Anderson Cancer Center. Her clinical responsibilities include providing risk assessment and genetic counseling services to individuals at risk for an inherited predisposition to hematologic malignancies (leukemia). She is the Genetic Counselor for the Hereditary Hematologic Malignancies Clinic (HHMC).

Mary K. Hughes, MS, RN, CNS, CT, is a Outpatient, Clinical Nurse Specialist with the University of Texas MD Anderson Cancer Center Psychiatry Department where she works with a team of mental health professionals to support patients, families and caregivers from diagnosis to treatment to survivorship.